United Therapeutics Co. (NASDAQ:UTHR) Receives Consensus Rating of Buy from Analysts

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has been given a consensus rating of “Buy” by the eight research firms that are covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have covered the stock in the last […]

Related Keywords

United States ,Nilda Mesa ,Christopher Causey ,United Therapeutics Corporation ,Northwestern Mutual Wealth Management Co ,Atlas Capital Advisors ,Nasdaq ,United Therapeutics Company Profile ,Jpmorgan Chase Co ,Massmutual Trust Co ,United Therapeutics Co ,Wells Fargo Company ,Hazlett Burt Watson Inc ,Morgan Stanley ,United Therapeutics ,Get Free Report ,Therapeutics Trading Down ,Director Christopher Causey ,Director Nilda Mesa ,Ivy Capital Management ,Capital Advisors ,Northwestern Mutual Wealth Management ,Mutual Wealth Management ,Get Free ,Therapeutics Corporation ,Remunity Pump ,United Therapeutics Daily ,Nasdaq Uthr ,Suthr ,Medical ,91307c10 ,Ratings ,Consensus ,